Could potentially take a significant jump on any good news considering it dropped so much last week. Maybe some people are jumping in for a quick win and will exit shortly thereafter.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
